Effect of Omega-3-fatty Acids on Blood Levels Omega-3 Fatty Acids in Patients With Age-related Macular Degeneration

Completed · Not applicable

Conditions studied: Macular Degeneration

In brief

The effect of omega-3-fatty acids on blood levels omega-3 fatty acids in patients with age-related macular degeneration.

Key facts

Study ID

NCT01653184

Run by

Wills Eye

People needed

30

Starts

2012-07-01

Expected to finish

2014-03-01

Last updated by the study team

2016-12-12

Who can join

Age: 55 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Ability to provide written informed consent and comply with study assessments for the full duration of the study.
• Have AREDS category 3 or 4 disease.
• Category 3: Many medium sized drusen or one or more large drusen in one or both eyes
• Category 4: Geographic atrophy or choroidal neovascularization in one eye.

You may not qualify if…

• Women of child-bearing age with positive urine pregnancy tests or desire to conceive during the course of the study.
• Patients with a known fish allergy.
• Patients currently taking supplementation with omega-3 fatty acids and have an omega-3 index of greater than 4%.

Where it is running

• Mid Atlantic Retina- Cherry Hill — Cherry Hill, New Jersey, United States
• Mid Atlantic Retina - Bethlehem — Bethlehem, Pennsylvania, United States
• Mid Atlantic Retina- Hungtindon Valley — Huntingdon Valley, Pennsylvania, United States
• Mid Atlantic Retina- Wills Eye Institute — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.